LATAM MedTech Insights
autor: Ran Chen
Colombia's UDI Mandate: Pure Global on a New MedTech Compliance Trap
O tym podcaście
Welcome to LATAM MedTech Insights, your essential guide to the booming medical technology and digital health sector across Latin America. Each episode, we dissect the key trends, investment opportunities, and regulatory news shaping the industry. Join us for in-depth interviews with the innovators, investors, and policymakers driving the future of healthcare from Mexico to Brazil.
Odcinki
Najnowsze 20 z 188 odcinków
- Colombia's UDI Mandate: Pure Global on a New MedTech Compliance Trap · 2 minThis episode of LATAM MedTech Insights dives into a sudden and critical regulatory update from Colombia's INVIMA. Last week's clarification on Unique Device Identification (UDI)…
- Pure Global: Chile's MedTech Surprise - Cracking Decree 25's Hidden Regulatory Hurdles. · 2 minThis week on LATAM MedTech Insights, we dissect the impactful new regulations quietly introduced in Chile. Exempt Decree No. 25 has significantly expanded the oversight of the…
- Brazil's AI MedTech Firewall: Pure Global on Cracking ANVISA's Surprise Cybersecurity Mandate · 2 minLast week, Brazil's regulatory landscape for MedTech was redefined. ANVISA, the national health agency, unexpectedly rolled out a stringent new framework mandating advanced…
- Pure Global: Brazil's New SaMD Hurdle & The Hidden AI Challenge · 2 minThis week, we dissect a game-changing regulatory update from Brazil's ANVISA that directly impacts AI-powered medical devices. Brazil has introduced a mandatory "Algorithm Change…
- Pure Global: Brazil's AI MedTech Shock—Navigating ANVISA's New Data Rules. · 2 minThis week, we dissect the immediate fallout from Brazil's surprise new regulation, ANVISA RDC 925/2026. This sudden rule change for AI-powered medical software has blindsided…
- Pure Global: Brazil's AI MedTech Maze - Cracking ANVISA's New Software Rules · 2 minBrazil's health regulatory agency, ANVISA, has just released a groundbreaking new framework for Software as a Medical Device (SaMD), creating significant new challenges for…
- Pure Global: Brazil's AI Device Maze - Decoding ANVISA's Unseen SaMD Hurdles · 2 minThis week, we dive into a major regulatory shift in Latin America's largest market. Brazil's ANVISA has just rolled out a comprehensive and demanding new framework for Software…
- Pure Global: Brazil's AI MedTech Surge - Unlocking ANVISA's New Fast-Track Secrets. · 2 minIn this episode, we dissect the groundbreaking new resolution from Brazil's ANVISA that creates a fast-track approval pathway for AI-powered Software as a Medical Device (SaMD)…
- Brazil's ANVISA Gambit: Decoding the 2027 MedTech Agenda | Pure Global Insights · 2 minBrazil's regulatory body, ANVISA, has just released its strategic agenda for 2026-2027, signaling the most significant shift in the country's MedTech landscape in years. This…
- Brazil's Cyber Shock: Pure Global on ANVISA's Hidden Hurdles for Connected Devices. · 2 minIn this episode, we dissect the breaking news from Brazil where ANVISA has just released an urgent and aggressive new cybersecurity resolution, RDC 999/2026. This sudden move…
- Pure Global: Mexico's COFEPRIS Platform - Navigating the Hidden Digital Submission Traps. · 2 minThis week on LATAM MedTech Insights, we are tackling the crisis unfolding with Mexico's new digital submission platform for medical devices. COFEPRIS aimed for modernization, but…
- Pure Global: Brazil's AI MedTech Fast-Track, Decoding ANVISA's Hidden Compliance Hurdles · 2 minThis week, we dissect the seismic news from Brazil. ANVISA just launched an accelerated approval pathway for AI-powered medical devices, creating a potential gold rush for…
- Pure Global: Brazil's AI Software Gambit - Decoding ANVISA's New Compliance Maze. · 2 minBrazil's health regulator, ANVISA, has just shaken up the digital health landscape. A new draft resolution brings critical clarifications for AI-powered medical software…
- Pure Global: Costa Rica's MedTech Gambit - The New Local-Only Fast Track · 2 minThis week, we dive into a game-changing development out of Costa Rica. Long known as a premier manufacturing hub for MedTech, the country just launched the "Medical Device…
- Pure Global: Brazil's ANVISA Shift – Cracking the Code of the New RDC 751 Landscape. · 2 minThis week, we dissect the latest critical guidance from Brazil's ANVISA on RDC 751, a regulation that aligns the country's medical device framework with the EU's MDR. This is…
- Brazil's AI MedTech Surprise: Pure Global on ANVISA's New Rulebook & Hidden Data Traps · 2 minThis week on LATAM MedTech Insights, we dissect the groundbreaking new regulatory framework released by Brazil's ANVISA for AI-powered medical devices. Announced just last week…
- Pure Global: Brazil's MedTech Renewal Riddle - Cracking ANVISA's New 10-Year Cycle. · 2 minThis week on LATAM MedTech Insights, we dissect a game-changing update from Brazil's regulatory agency, ANVISA. The validity for medical device registrations has been doubled…
- Pure Global: Brazil's ANVISA Deadline Chaos - A Survival Guide for MedTech. · 2 minLast week, Brazil's ANVISA sent shockwaves through the MedTech industry by announcing a hard deadline for transitioning all medical device registrations to the new RDC 751…
- Mexico's Digital Gate: Pure Global on COFEPRIS's Chaotic New Platform. · 2 minMexico's regulatory authority, COFEPRIS, has just launched its mandatory all-digital submission platform, DigiPRIS. While this move promises to streamline market access, the…
- Pure Global's Brazil Brief: Decoding ANVISA's New AI Rules for MedTech Innovators. · 2 minIn this episode, we dive into a critical regulatory update from Brazil that is sending shockwaves through the digital health community. Last week, ANVISA unexpectedly released a…








